Back to Results

Thermo Fisher Scientific Inc (TMO)

Featured in High-Momentum Stocks

Thermo Fisher Scientific Inc. is a healthcare company listed on the New York Stock Exchange under the ticker TMO. The company develops and supplies life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Its operations are organized into four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.

Through these businesses, Thermo Fisher serves customers involved in biological and medical research, drug and vaccine development, clinical diagnostics, and a range of pharmaceutical, biotechnology, academic, government, environmental, and industrial applications. The company also provides products and services for clinical laboratories, transplant diagnostics, microbiology, and healthcare market channels. Thermo Fisher Scientific was founded in 1956 and is headquartered in Waltham, Massachusetts.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-TMO
$576.04
-14.5% Downside
Fair
$750.92
11.4% Upside
Fair
Good
0.3%
February 4, 2027
35.2x
4.5x
5.3x
249.1 B
284.6 B
14.2%
99.7%
4.7
9.5%
107.4%
Valuation • Fair Value

Thermo Fisher Scientific Inc (NYSE-TMO) Fair Value by Valuation Model

Review the available estimates for Thermo Fisher Scientific Inc (NYSE-TMO), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$576.04

Estimated downside of 14.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$558.69

Discounted cash flow valuation reference.

Ben Graham Formula Value

$212.22

Classic Ben Graham valuation formula reference.

DDM Fair Value

$546.92

Dividend discount model valuation reference.

Comps Fair Value

$603.11

Comparable-company valuation reference.

Analyst Price Target

$750.92

Analysts imply upside of 11.4%.

How to read these valuation models

Use the 7 available valuation references for Thermo Fisher Scientific Inc (NYSE-TMO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Thermo Fisher Scientific Inc (NYSE-TMO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

47.351 B

Current operating scale indicator.

Revenue Forecast

47.971 B

Forward revenue estimate.

EBITDA

12.197 B

Current operating profitability reference.

EBITDA Forecast

12.546 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Thermo Fisher Scientific Inc (NYSE-TMO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Thermo Fisher Scientific Inc (NYSE-TMO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.64

No elevated caution signal from this screen.

Altman Z-Score

4.7

Relatively strong balance-sheet zone.

FCF / Net Income

107.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Thermo Fisher Scientific Inc (NYSE-TMO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Thermo Fisher Scientific Inc (NYSE-TMO)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 4, 2027

Days to Earnings

103

Dividend Yield

0.3%

Current income yield reference.

Payout Ratio

9.5%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Thermo Fisher Scientific Inc (NYSE-TMO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Thermo Fisher Scientific Inc (NYSE-TMO) Stock Forecast & Technical Outlook

Review Thermo Fisher Scientific Inc (NYSE-TMO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Thermo Fisher Scientific Inc (NYSE-TMO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Thermo Fisher Scientific Inc (NYSE-TMO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Thermo Fisher Scientific Inc (NYSE-TMO) has a Strong Buy consensus, with 20 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 20
Hold 3
Sell 0
FAQ • Fast Investor Answers

Thermo Fisher Scientific Inc (NYSE-TMO) Stock FAQ

Data-supported answers about Thermo Fisher Scientific Inc (NYSE-TMO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$576.04
Estimated downside 14.5%
Valuation Rating
Overvalued
Estimated downside of 14.5%
Analyst Target
$750.92
Implied upside 11.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Thermo Fisher Scientific Inc (NYSE-TMO) is $576.04. This implies an estimated downside of 14.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 14.5% versus the current market price.

The available analyst price target for Thermo Fisher Scientific Inc (NYSE-TMO) is $750.92. The analyst target implies estimated upside of 11.4%.

The current financial health read for Thermo Fisher Scientific Inc (NYSE-TMO) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Thermo Fisher Scientific Inc (NYSE-TMO) is February 4, 2027.

Based on the current data, dividend yield is 0.3%.

The current P/E ratio listed for Thermo Fisher Scientific Inc (NYSE-TMO) is 35.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Thermo Fisher Scientific Inc is 249.1 B.

The current enterprise value listed for Thermo Fisher Scientific Inc is 284.6 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Thermo Fisher Scientific Inc is NYSE-TMO, and the stock is listed on NYSE.

Thermo Fisher Scientific Inc (NYSE-TMO) is listed on NYSE.

The current debt-to-total-capital ratio listed for Thermo Fisher Scientific Inc is 14.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Thermo Fisher Scientific Inc is 99.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

DHR NYSE Danaher Corporation Fair Value Fair Market Cap 162.2 B
A NYSE Agilent Technologies Inc Fair Value Fair Market Cap 48.793 B
IQV NYSE IQVIA Holdings Inc Fair Value Fair Market Cap 45.983 B
WAT NYSE Waters Corporation Fair Value Overvalued Market Cap 44.572 B
ILMN NASDAQ Illumina Inc Fair Value Overvalued Market Cap 40.682 B
MTD NYSE Mettler-Toledo International Inc Fair Value Fair Market Cap 33.467 B
WST NYSE West Pharmaceutical Services Inc Fair Value Fair Market Cap 27.598 B
MEDP NASDAQ Medpace Holdings Inc Fair Value Fair Market Cap 18.715 B
RVTY NYSE Revvity Inc Fair Value Overvalued Market Cap 17.717 B
CRL NYSE Charles River Laboratories Fair Value Overvalued Market Cap 16.488 B
ICLR NASDAQ ICON PLC Fair Value Fair Market Cap 14.294 B
TEM NASDAQ Tempus AI Inc Fair Value Overvalued Market Cap 12.2 B
AVTR NYSE Avantor Inc Fair Value Fair Market Cap 11.694 B
TECH NASDAQ Bio-Techne Corp Fair Value Fair Market Cap 11.377 B
QGEN NYSE Qiagen NV Fair Value Fair Market Cap 10.421 B
RGEN NASDAQ Repligen Corporation Fair Value Overvalued Market Cap 9.985 B
BIOB NYSE Bio-Rad Laboratories B Fair Value Fair Market Cap 9.862 B
BIO NYSE Bio-Rad Laboratories Inc Fair Value Fair Market Cap 9.862 B
TXG NASDAQ 10X Genomics Inc Fair Value Overvalued Market Cap 9.322 B
BRKR NASDAQ Bruker Corporation Fair Value Fair Market Cap 8.774 B